ON-DEMAND Prevention and early management in primary care | Diabetes on the Net

Diabetes on the Net is intended for healthcare professionals

This video was originally broadcast on 22 June 2020. Please note that the speaker is not able to answer questions from attendees watching the video on-demand.

Prevention and early management in primary care

Speaker: Pam Brown, GP, Swansea
Date of session: 22 June 2020

Smart Updates – Prevention and early management in primary care

References

  1. Buse JB et al (2020) Diabetologia 63: 221−28.
  2. Evert AB et al (2019) Diabetes Care 42: 731–54.
  3. Diabetes UK (2018) Evidence-based nutrition guidelines for the prevention and management of diabetes. Diabetes UK, London.
  4. Holman RR et al (2008) N Engl J Med 359: 1565–76.
  5. Aroda VR et al (2017) Diabetologia 60: 1601–11.

VIRTUAL SMART UPDATE IN DIABETES PROGRAMME 2020 View the presentation delivered by Dr. Pam Brown as she examines the following topics: 1. Pre-diabetes: the role of primary care
  • Professional frameworks: NHS Diabetes Prevention Programme, Quality and Outcomes Framework
  • Behaviour change programmes and other early interventions
2. Achieving glycaemic targets early and preventing long-term complications in type 2 diabetes
  • Addressing clinical inertia
3. Case study 1: pre-diabetes

Practical experiences from running an adeno-associated virus gene therapy trials: The Principal Investigator’s perspective

XX September 2020

Complete the registration form

XX Month 2020

Complete the registration form

We use cookies to ensure that we give you the best experience on our website. Some may have been set already. If you continue without changing your settings, we’ll assume that you are happy to receive all cookies on this website. Read about how we use cookies. If you have any concerns about this, please click here to find out more.

* Mandatory Field
Your data is being collected by OmniaMed Communications on behalf of Novo Nordisk solely for the purpose of processing your registration. Your details will not be shared with any parties other than OmniaMed Communications and Novo Nordisk.